APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gamma Globulin Therpeautic Agent

Compare research editions
View pricing & licenses

Selected research

Industry Research

Gamma Globulin Therpeautic Agent Industry Research Report 2026

28 December 2025137 pages

Choose your research edition.

Industry ResearchGamma Globulin Therpeautic Agent Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Gamma Globulin Therpeautic Agent Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Gamma Globulin Therpeautic Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gamma Globulin Therpeautic Agent Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Gamma Globulin Therpeautic Agent Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Gamma Globulin Therpeautic Agent market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Gamma Globulin Therpeautic Agent is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Gamma Globulin Therpeautic Agent is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Gamma Globulin Therpeautic Agent is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Gamma Globulin Therpeautic Agent include ADMA Biologics, Baxter, Biotest, BPL, Grifols, Kedrion Biopharma, LFB Group, Octapharma and Takeda, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Gamma Globulin Therpeautic Agent market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Gamma Globulin Therpeautic Agent Market by Company

ADMA Biologics

Baxter

Biotest

BPL

Grifols

Kedrion Biopharma

LFB Group

Octapharma

Takeda

Beijing Bohui Innovation Biotechnology

Hualan Biological

Pacific Shuanglin Bio-pharmacy

Shanghai RAAS

Sichuan Yuanda Shuyang

CBPO

Beijing Tiantan Biological

Shenzhen Weiguang Biological

CNBG

Gamma Globulin Therpeautic Agent Segment by Type

Gamma Globulin Liquid

Gamma Globulin Powder

Gamma Globulin Therpeautic Agent Segment by Application

Autoimmune Disease

Immunodeficiency

Acute Infection

Gamma Globulin Therpeautic Agent Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gamma Globulin Therpeautic Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gamma Globulin Therpeautic Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gamma Globulin Therpeautic Agent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Gamma Globulin Therpeautic Agent manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Gamma Globulin Therpeautic Agent by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Gamma Globulin Therpeautic Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Gamma Globulin Therpeautic Agent Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Gamma Globulin Therpeautic Agent Sales (Kg) of Manufacturers (2021-2026) Table 7. Global Gamma Globulin Therpeautic Agent Sales Market Share by Manufacturers (2021-2026) Table 8. Global Gamma Globulin Therpeautic Agent Revenue of Manufacturers (2021-2026) Table 9. Global Gamma Globulin Therpeautic Agent Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Gamma Globulin Therpeautic Agent Average Price (US$/g) of Manufacturers (2021-2026) Table 11. Global Gamma Globulin Therpeautic Agent Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Gamma Globulin Therpeautic Agent, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Gamma Globulin Therpeautic Agent, Product Type & Application Table 14. Global Gamma Globulin Therpeautic Agent Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Gamma Globulin Therpeautic Agent by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. ADMA Biologics Company Information Table 19. ADMA Biologics Business Overview Table 20. ADMA Biologics Gamma Globulin Therpeautic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 21. ADMA Biologics Gamma Globulin Therpeautic Agent Product Portfolio Table 22. ADMA Biologics Recent Developments Table 23. Baxter Company Information Table 24. Baxter Business Overview Table 25. Baxter Gamma Globulin Therpeautic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 26. Baxter Gamma Globulin Therpeautic Agent Product Portfolio Table 27. Baxter Recent Developments Table 28. Biotest Company Information Table 29. Biotest Business Overview Table 30. Biotest Gamma Globulin Therpeautic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 31. Biotest Gamma Globulin Therpeautic Agent Product Portfolio Table 32. Biotest Recent Developments Table 33. BPL Company Information Table 34. BPL Business Overview Table 35. BPL Gamma Globulin Therpeautic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 36. BPL Gamma Globulin Therpeautic Agent Product Portfolio Table 37. BPL Recent Developments Table 38. Grifols Company Information Table 39. Grifols Business Overview Table 40. Grifols Gamma Globulin Therpeautic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 41. Grifols Gamma Globulin Therpeautic Agent Product Portfolio Table 42. Grifols Recent Developments Table 43. Kedrion Biopharma Company Information Table 44. Kedrion Biopharma Business Overview Table 45. Kedrion Biopharma Gamma Globulin Therpeautic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 46. Kedrion Biopharma Gamma Globulin Therpeautic Agent Product Portfolio Table 47. Kedrion Biopharma Recent Developments Table 48. LFB Group Company Information Table 49. LFB Group Business Overview Table 50. LFB Group Gamma Globulin Therpeautic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 51. LFB Group Gamma Globulin Therpeautic Agent Product Portfolio Table 52. LFB Group Recent Developments Table 53. Octapharma Company Information Table 54. Octapharma Business Overview Table 55. Octapharma Gamma Globulin Therpeautic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 56. Octapharma Gamma Globulin Therpeautic Agent Product Portfolio Table 57. Octapharma Recent Developments Table 58. Takeda Company Information Table 59. Takeda Business Overview Table 60. Takeda Gamma Globulin Therpeautic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 61. Takeda Gamma Globulin Therpeautic Agent Product Portfolio Table 62. Takeda Recent Developments Table 63. Beijing Bohui Innovation Biotechnology Company Information Table 64. Beijing Bohui Innovation Biotechnology Business Overview Table 65. Beijing Bohui Innovation Biotechnology Gamma Globulin Therpeautic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 66. Beijing Bohui Innovation Biotechnology Gamma Globulin Therpeautic Agent Product Portfolio Table 67. Beijing Bohui Innovation Biotechnology Recent Developments Table 68. Hualan Biological Company Information Table 69. Hualan Biological Business Overview Table 70. Hualan Biological Gamma Globulin Therpeautic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 71. Hualan Biological Gamma Globulin Therpeautic Agent Product Portfolio Table 72. Hualan Biological Recent Developments Table 73. Pacific Shuanglin Bio-pharmacy Company Information Table 74. Pacific Shuanglin Bio-pharmacy Business Overview Table 75. Pacific Shuanglin Bio-pharmacy Gamma Globulin Therpeautic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 76. Pacific Shuanglin Bio-pharmacy Gamma Globulin Therpeautic Agent Product Portfolio Table 77. Pacific Shuanglin Bio-pharmacy Recent Developments Table 78. Shanghai RAAS Company Information Table 79. Shanghai RAAS Business Overview Table 80. Shanghai RAAS Gamma Globulin Therpeautic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 81. Shanghai RAAS Gamma Globulin Therpeautic Agent Product Portfolio Table 82. Shanghai RAAS Recent Developments Table 83. Sichuan Yuanda Shuyang Company Information Table 84. Sichuan Yuanda Shuyang Business Overview Table 85. Sichuan Yuanda Shuyang Gamma Globulin Therpeautic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 86. Sichuan Yuanda Shuyang Gamma Globulin Therpeautic Agent Product Portfolio Table 87. Sichuan Yuanda Shuyang Recent Developments Table 88. CBPO Company Information Table 89. CBPO Business Overview Table 90. CBPO Gamma Globulin Therpeautic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 91. CBPO Gamma Globulin Therpeautic Agent Product Portfolio Table 92. CBPO Recent Developments Table 93. Beijing Tiantan Biological Company Information Table 94. Beijing Tiantan Biological Business Overview Table 95. Beijing Tiantan Biological Gamma Globulin Therpeautic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 96. Beijing Tiantan Biological Gamma Globulin Therpeautic Agent Product Portfolio Table 97. Beijing Tiantan Biological Recent Developments Table 98. Shenzhen Weiguang Biological Company Information Table 99. Shenzhen Weiguang Biological Business Overview Table 100. Shenzhen Weiguang Biological Gamma Globulin Therpeautic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 101. Shenzhen Weiguang Biological Gamma Globulin Therpeautic Agent Product Portfolio Table 102. Shenzhen Weiguang Biological Recent Developments Table 103. CNBG Company Information Table 104. CNBG Business Overview Table 105. CNBG Gamma Globulin Therpeautic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 106. CNBG Gamma Globulin Therpeautic Agent Product Portfolio Table 107. CNBG Recent Developments Table 108. Global Gamma Globulin Therpeautic Agent Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 109. Global Gamma Globulin Therpeautic Agent Sales by Region (2021-2026) & (Kg) Table 110. Global Gamma Globulin Therpeautic Agent Sales Market Share by Region (2021-2026) Table 111. Global Gamma Globulin Therpeautic Agent Sales by Region (2027-2032) & (Kg) Table 112. Global Gamma Globulin Therpeautic Agent Sales Market Share by Region (2027-2032) Table 113. Global Gamma Globulin Therpeautic Agent Revenue by Region (2021-2026) & (US$ Million) Table 114. Global Gamma Globulin Therpeautic Agent Revenue Market Share by Region (2021-2026) Table 115. Global Gamma Globulin Therpeautic Agent Revenue by Region (2027-2032) & (US$ Million) Table 116. Global Gamma Globulin Therpeautic Agent Revenue Market Share by Region (2027-2032) Table 117. North America Gamma Globulin Therpeautic Agent Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. North America Gamma Globulin Therpeautic Agent Sales by Country (2021-2026) & (Kg) Table 119. North America Gamma Globulin Therpeautic Agent Sales by Country (2027-2032) & (Kg) Table 120. North America Gamma Globulin Therpeautic Agent Revenue by Country (2021-2026) & (US$ Million) Table 121. North America Gamma Globulin Therpeautic Agent Revenue by Country (2027-2032) & (US$ Million) Table 122. Europe Gamma Globulin Therpeautic Agent Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Europe Gamma Globulin Therpeautic Agent Sales by Country (2021-2026) & (Kg) Table 124. Europe Gamma Globulin Therpeautic Agent Sales by Country (2027-2032) & (Kg) Table 125. Europe Gamma Globulin Therpeautic Agent Revenue by Country (2021-2026) & (US$ Million) Table 126. Europe Gamma Globulin Therpeautic Agent Revenue by Country (2027-2032) & (US$ Million) Table 127. Asia Pacific Gamma Globulin Therpeautic Agent Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Asia Pacific Gamma Globulin Therpeautic Agent Sales by Country (2021-2026) & (Kg) Table 129. Asia Pacific Gamma Globulin Therpeautic Agent Sales by Country (2027-2032) & (Kg) Table 130. Asia Pacific Gamma Globulin Therpeautic Agent Revenue by Country (2021-2026) & (US$ Million) Table 131. Asia Pacific Gamma Globulin Therpeautic Agent Revenue by Country (2027-2032) & (US$ Million) Table 132. South America Gamma Globulin Therpeautic Agent Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. South America Gamma Globulin Therpeautic Agent Sales by Country (2021-2026) & (Kg) Table 134. South America Gamma Globulin Therpeautic Agent Sales by Country (2027-2032) & (Kg) Table 135. South America Gamma Globulin Therpeautic Agent Revenue by Country (2021-2026) & (US$ Million) Table 136. South America Gamma Globulin Therpeautic Agent Revenue by Country (2027-2032) & (US$ Million) Table 137. Middle East and Africa Gamma Globulin Therpeautic Agent Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Middle East and Africa Gamma Globulin Therpeautic Agent Sales by Country (2021-2026) & (Kg) Table 139. Middle East and Africa Gamma Globulin Therpeautic Agent Sales by Country (2027-2032) & (Kg) Table 140. Middle East and Africa Gamma Globulin Therpeautic Agent Revenue by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Gamma Globulin Therpeautic Agent Revenue by Country (2027-2032) & (US$ Million) Table 142. Global Gamma Globulin Therpeautic Agent Sales by Type (2021-2026) & (Kg) Table 143. Global Gamma Globulin Therpeautic Agent Sales by Type (2027-2032) & (Kg) Table 144. Global Gamma Globulin Therpeautic Agent Sales Market Share by Type (2021-2026) Table 145. Global Gamma Globulin Therpeautic Agent Sales Market Share by Type (2027-2032) Table 146. Global Gamma Globulin Therpeautic Agent Revenue by Type (2021-2026) & (US$ Million) Table 147. Global Gamma Globulin Therpeautic Agent Revenue by Type (2027-2032) & (US$ Million) Table 148. Global Gamma Globulin Therpeautic Agent Revenue Market Share by Type (2021-2026) Table 149. Global Gamma Globulin Therpeautic Agent Revenue Market Share by Type (2027-2032) Table 150. Global Gamma Globulin Therpeautic Agent Price by Type (2021-2026) & (US$/g) Table 151. Global Gamma Globulin Therpeautic Agent Price by Type (2027-2032) & (US$/g) Table 152. Global Gamma Globulin Therpeautic Agent Sales by Application (2021-2026) & (Kg) Table 153. Global Gamma Globulin Therpeautic Agent Sales by Application (2027-2032) & (Kg) Table 154. Global Gamma Globulin Therpeautic Agent Sales Market Share by Application (2021-2026) Table 155. Global Gamma Globulin Therpeautic Agent Sales Market Share by Application (2027-2032) Table 156. Global Gamma Globulin Therpeautic Agent Revenue by Application (2021-2026) & (US$ Million) Table 157. Global Gamma Globulin Therpeautic Agent Revenue by Application (2027-2032) & (US$ Million) Table 158. Global Gamma Globulin Therpeautic Agent Revenue Market Share by Application (2021-2026) Table 159. Global Gamma Globulin Therpeautic Agent Revenue Market Share by Application (2027-2032) Table 160. Global Gamma Globulin Therpeautic Agent Price by Application (2021-2026) & (US$/g) Table 161. Global Gamma Globulin Therpeautic Agent Price by Application (2027-2032) & (US$/g) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Gamma Globulin Therpeautic Agent Distributors List Table 165. Gamma Globulin Therpeautic Agent Customers List Table 166. Gamma Globulin Therpeautic Agent Industry Trends Table 167. Gamma Globulin Therpeautic Agent Industry Drivers Table 168. Gamma Globulin Therpeautic Agent Industry Restraints Table 169. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Gamma Globulin Therpeautic Agent Product Image Figure 5. Global Gamma Globulin Therpeautic Agent Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Gamma Globulin Therpeautic Agent Market Size (2021-2032) & (US$ Million) Figure 7. Global Gamma Globulin Therpeautic Agent Sales (2021-2032) & (Kg) Figure 8. Global Gamma Globulin Therpeautic Agent Average Price (US$/g) & (2021-2032) Figure 9. Gamma Globulin Liquid Product Image Figure 10. Gamma Globulin Powder Product Image Figure 11. Autoimmune Disease Product Image Figure 12. Immunodeficiency Product Image Figure 13. Acute Infection Product Image Figure 14. Global Gamma Globulin Therpeautic Agent Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Gamma Globulin Therpeautic Agent, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Gamma Globulin Therpeautic Agent Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Gamma Globulin Therpeautic Agent Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Gamma Globulin Therpeautic Agent Sales by Region in 2025 Figure 20. Global Gamma Globulin Therpeautic Agent Revenue by Region in 2025 Figure 21. North America Gamma Globulin Therpeautic Agent Market Size by Country in 2025 Figure 22. North America Gamma Globulin Therpeautic Agent Sales Market Share by Country (2021-2032) Figure 23. North America Gamma Globulin Therpeautic Agent Revenue Market Share by Country (2021-2032) Figure 24. United States Gamma Globulin Therpeautic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Gamma Globulin Therpeautic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Gamma Globulin Therpeautic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Gamma Globulin Therpeautic Agent Market Size by Country in 2025 Figure 28. Europe Gamma Globulin Therpeautic Agent Sales Market Share by Country (2021-2032) Figure 29. Europe Gamma Globulin Therpeautic Agent Revenue Market Share by Country (2021-2032) Figure 30. Germany Gamma Globulin Therpeautic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Gamma Globulin Therpeautic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Gamma Globulin Therpeautic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Gamma Globulin Therpeautic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Gamma Globulin Therpeautic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Gamma Globulin Therpeautic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Gamma Globulin Therpeautic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Gamma Globulin Therpeautic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Gamma Globulin Therpeautic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Gamma Globulin Therpeautic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Gamma Globulin Therpeautic Agent Market Size by Country in 2025 Figure 41. Asia Pacific Gamma Globulin Therpeautic Agent Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Gamma Globulin Therpeautic Agent Revenue Market Share by Country (2021-2032) Figure 43. China Gamma Globulin Therpeautic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Gamma Globulin Therpeautic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Gamma Globulin Therpeautic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Gamma Globulin Therpeautic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Gamma Globulin Therpeautic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Gamma Globulin Therpeautic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Gamma Globulin Therpeautic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Gamma Globulin Therpeautic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Gamma Globulin Therpeautic Agent Market Size by Country in 2025 Figure 52. South America Gamma Globulin Therpeautic Agent Sales Market Share by Country (2021-2032) Figure 53. South America Gamma Globulin Therpeautic Agent Revenue Market Share by Country (2021-2032) Figure 54. Brazil Gamma Globulin Therpeautic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Gamma Globulin Therpeautic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Gamma Globulin Therpeautic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Gamma Globulin Therpeautic Agent Market Size by Country in 2025 Figure 58. Middle East and Africa Gamma Globulin Therpeautic Agent Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Gamma Globulin Therpeautic Agent Revenue Market Share by Country (2021-2032) Figure 60. Egypt Gamma Globulin Therpeautic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Gamma Globulin Therpeautic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Gamma Globulin Therpeautic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Gamma Globulin Therpeautic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Gamma Globulin Therpeautic Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Gamma Globulin Therpeautic Agent Sales Market Share by Type (2021-2032) Figure 66. Global Gamma Globulin Therpeautic Agent Revenue Market Share by Type (2021-2032) Figure 67. Global Gamma Globulin Therpeautic Agent Price (US$/g) by Type (2021-2032) Figure 68. Global Gamma Globulin Therpeautic Agent Sales Market Share by Application (2021-2032) Figure 69. Global Gamma Globulin Therpeautic Agent Revenue Market Share by Application (2021-2032) Figure 70. Global Gamma Globulin Therpeautic Agent Price (US$/g) by Application (2021-2032) Figure 71. Gamma Globulin Therpeautic Agent Value Chain Figure 72. Gamma Globulin Therpeautic Agent Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Gamma Globulin Therpeautic Agent Industry Opportunities and Challenges

Scope & coverage.

Types
  • Gamma Globulin Liquid
  • Gamma Globulin Powder
Applications
  • Autoimmune Disease
  • Immunodeficiency
  • Acute Infection
Companies covered
  • ADMA Biologics
  • Baxter
  • Biotest
  • BPL
  • Grifols
  • Kedrion Biopharma
  • LFB Group
  • Octapharma
  • Takeda
  • Beijing Bohui Innovation Biotechnology
  • Hualan Biological
  • Pacific Shuanglin Bio-pharmacy
  • Shanghai RAAS
  • Sichuan Yuanda Shuyang
  • CBPO
  • Beijing Tiantan Biological
  • Shenzhen Weiguang Biological
  • CNBG

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Gamma Globulin Therpeautic Agent Market Size (2021-2032)
  4. 2.2.2 Global Gamma Globulin Therpeautic Agent Sales (2021-2032)
  5. 2.2.3 Global Gamma Globulin Therpeautic Agent Market Average Price (2021-2032)
  6. 2.3 Gamma Globulin Therpeautic Agent by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Gamma Globulin Liquid
  9. 2.3.3 Gamma Globulin Powder
  10. 2.4 Gamma Globulin Therpeautic Agent by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Autoimmune Disease
  13. 2.4.3 Immunodeficiency
  14. 2.4.4 Acute Infection
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Gamma Globulin Therpeautic Agent Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Gamma Globulin Therpeautic Agent Sales (Kg) of Manufacturers (2021-2026)
  3. 3.3 Global Gamma Globulin Therpeautic Agent Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Gamma Globulin Therpeautic Agent Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Gamma Globulin Therpeautic Agent Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Gamma Globulin Therpeautic Agent, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Gamma Globulin Therpeautic Agent, Product Type & Application
  8. 3.8 Global Manufacturers of Gamma Globulin Therpeautic Agent, Established Date
  9. 3.9 Global Gamma Globulin Therpeautic Agent Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 ADMA Biologics
  2. 4.1.1 ADMA Biologics Company Information
  3. 4.1.2 ADMA Biologics Business Overview
  4. 4.1.3 ADMA Biologics Gamma Globulin Therpeautic Agent Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 ADMA Biologics Gamma Globulin Therpeautic Agent Product Portfolio
  6. 4.1.5 ADMA Biologics Recent Developments
  7. 4.2 Baxter
  8. 4.2.1 Baxter Company Information
  9. 4.2.2 Baxter Business Overview
  10. 4.2.3 Baxter Gamma Globulin Therpeautic Agent Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Baxter Gamma Globulin Therpeautic Agent Product Portfolio
  12. 4.2.5 Baxter Recent Developments
  13. 4.3 Biotest
  14. 4.3.1 Biotest Company Information
  15. 4.3.2 Biotest Business Overview
  16. 4.3.3 Biotest Gamma Globulin Therpeautic Agent Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Biotest Gamma Globulin Therpeautic Agent Product Portfolio
  18. 4.3.5 Biotest Recent Developments
  19. 4.4 BPL
  20. 4.4.1 BPL Company Information
  21. 4.4.2 BPL Business Overview
  22. 4.4.3 BPL Gamma Globulin Therpeautic Agent Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 BPL Gamma Globulin Therpeautic Agent Product Portfolio
  24. 4.4.5 BPL Recent Developments
  25. 4.5 Grifols
  26. 4.5.1 Grifols Company Information
  27. 4.5.2 Grifols Business Overview
  28. 4.5.3 Grifols Gamma Globulin Therpeautic Agent Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Grifols Gamma Globulin Therpeautic Agent Product Portfolio
  30. 4.5.5 Grifols Recent Developments
  31. 4.6 Kedrion Biopharma
  32. 4.6.1 Kedrion Biopharma Company Information
  33. 4.6.2 Kedrion Biopharma Business Overview
  34. 4.6.3 Kedrion Biopharma Gamma Globulin Therpeautic Agent Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Kedrion Biopharma Gamma Globulin Therpeautic Agent Product Portfolio
  36. 4.6.5 Kedrion Biopharma Recent Developments
  37. 4.7 LFB Group
  38. 4.7.1 LFB Group Company Information
  39. 4.7.2 LFB Group Business Overview
  40. 4.7.3 LFB Group Gamma Globulin Therpeautic Agent Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 LFB Group Gamma Globulin Therpeautic Agent Product Portfolio
  42. 4.7.5 LFB Group Recent Developments
  43. 4.8 Octapharma
  44. 4.8.1 Octapharma Company Information
  45. 4.8.2 Octapharma Business Overview
  46. 4.8.3 Octapharma Gamma Globulin Therpeautic Agent Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Octapharma Gamma Globulin Therpeautic Agent Product Portfolio
  48. 4.8.5 Octapharma Recent Developments
  49. 4.9 Takeda
  50. 4.9.1 Takeda Company Information
  51. 4.9.2 Takeda Business Overview
  52. 4.9.3 Takeda Gamma Globulin Therpeautic Agent Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Takeda Gamma Globulin Therpeautic Agent Product Portfolio
  54. 4.9.5 Takeda Recent Developments
  55. 4.10 Beijing Bohui Innovation Biotechnology
  56. 4.10.1 Beijing Bohui Innovation Biotechnology Company Information
  57. 4.10.2 Beijing Bohui Innovation Biotechnology Business Overview
  58. 4.10.3 Beijing Bohui Innovation Biotechnology Gamma Globulin Therpeautic Agent Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Beijing Bohui Innovation Biotechnology Gamma Globulin Therpeautic Agent Product Portfolio
  60. 4.10.5 Beijing Bohui Innovation Biotechnology Recent Developments
  61. 4.11 Hualan Biological
  62. 4.11.1 Hualan Biological Company Information
  63. 4.11.2 Hualan Biological Business Overview
  64. 4.11.3 Hualan Biological Gamma Globulin Therpeautic Agent Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Hualan Biological Gamma Globulin Therpeautic Agent Product Portfolio
  66. 4.11.5 Hualan Biological Recent Developments
  67. 4.12 Pacific Shuanglin Bio-pharmacy
  68. 4.12.1 Pacific Shuanglin Bio-pharmacy Company Information
  69. 4.12.2 Pacific Shuanglin Bio-pharmacy Business Overview
  70. 4.12.3 Pacific Shuanglin Bio-pharmacy Gamma Globulin Therpeautic Agent Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Pacific Shuanglin Bio-pharmacy Gamma Globulin Therpeautic Agent Product Portfolio
  72. 4.12.5 Pacific Shuanglin Bio-pharmacy Recent Developments
  73. 4.13 Shanghai RAAS
  74. 4.13.1 Shanghai RAAS Company Information
  75. 4.13.2 Shanghai RAAS Business Overview
  76. 4.13.3 Shanghai RAAS Gamma Globulin Therpeautic Agent Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Shanghai RAAS Gamma Globulin Therpeautic Agent Product Portfolio
  78. 4.13.5 Shanghai RAAS Recent Developments
  79. 4.14 Sichuan Yuanda Shuyang
  80. 4.14.1 Sichuan Yuanda Shuyang Company Information
  81. 4.14.2 Sichuan Yuanda Shuyang Business Overview
  82. 4.14.3 Sichuan Yuanda Shuyang Gamma Globulin Therpeautic Agent Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Sichuan Yuanda Shuyang Gamma Globulin Therpeautic Agent Product Portfolio
  84. 4.14.5 Sichuan Yuanda Shuyang Recent Developments
  85. 4.15 CBPO
  86. 4.15.1 CBPO Company Information
  87. 4.15.2 CBPO Business Overview
  88. 4.15.3 CBPO Gamma Globulin Therpeautic Agent Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 CBPO Gamma Globulin Therpeautic Agent Product Portfolio
  90. 4.15.5 CBPO Recent Developments
  91. 4.16 Beijing Tiantan Biological
  92. 4.16.1 Beijing Tiantan Biological Company Information
  93. 4.16.2 Beijing Tiantan Biological Business Overview
  94. 4.16.3 Beijing Tiantan Biological Gamma Globulin Therpeautic Agent Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Beijing Tiantan Biological Gamma Globulin Therpeautic Agent Product Portfolio
  96. 4.16.5 Beijing Tiantan Biological Recent Developments
  97. 4.17 Shenzhen Weiguang Biological
  98. 4.17.1 Shenzhen Weiguang Biological Company Information
  99. 4.17.2 Shenzhen Weiguang Biological Business Overview
  100. 4.17.3 Shenzhen Weiguang Biological Gamma Globulin Therpeautic Agent Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Shenzhen Weiguang Biological Gamma Globulin Therpeautic Agent Product Portfolio
  102. 4.17.5 Shenzhen Weiguang Biological Recent Developments
  103. 4.18 CNBG
  104. 4.18.1 CNBG Company Information
  105. 4.18.2 CNBG Business Overview
  106. 4.18.3 CNBG Gamma Globulin Therpeautic Agent Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 CNBG Gamma Globulin Therpeautic Agent Product Portfolio
  108. 4.18.5 CNBG Recent Developments
5 Global Gamma Globulin Therpeautic Agent Market Scenario by Region
  1. 5.1 Global Gamma Globulin Therpeautic Agent Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Gamma Globulin Therpeautic Agent Sales by Region: 2021-2032
  3. 5.2.1 Global Gamma Globulin Therpeautic Agent Sales by Region: 2021-2026
  4. 5.2.2 Global Gamma Globulin Therpeautic Agent Sales by Region: 2027-2032
  5. 5.3 Global Gamma Globulin Therpeautic Agent Revenue by Region: 2021-2032
  6. 5.3.1 Global Gamma Globulin Therpeautic Agent Revenue by Region: 2021-2026
  7. 5.3.2 Global Gamma Globulin Therpeautic Agent Revenue by Region: 2027-2032
  8. 5.4 North America Gamma Globulin Therpeautic Agent Market Facts & Figures by Country
  9. 5.4.1 North America Gamma Globulin Therpeautic Agent Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Gamma Globulin Therpeautic Agent Sales by Country (2021-2032)
  11. 5.4.3 North America Gamma Globulin Therpeautic Agent Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Gamma Globulin Therpeautic Agent Market Facts & Figures by Country
  16. 5.5.1 Europe Gamma Globulin Therpeautic Agent Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Gamma Globulin Therpeautic Agent Sales by Country (2021-2032)
  18. 5.5.3 Europe Gamma Globulin Therpeautic Agent Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Gamma Globulin Therpeautic Agent Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Gamma Globulin Therpeautic Agent Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Gamma Globulin Therpeautic Agent Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Gamma Globulin Therpeautic Agent Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Gamma Globulin Therpeautic Agent Market Facts & Figures by Country
  41. 5.7.1 South America Gamma Globulin Therpeautic Agent Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Gamma Globulin Therpeautic Agent Sales by Country (2021-2032)
  43. 5.7.3 South America Gamma Globulin Therpeautic Agent Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Gamma Globulin Therpeautic Agent Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Gamma Globulin Therpeautic Agent Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Gamma Globulin Therpeautic Agent Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Gamma Globulin Therpeautic Agent Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Gamma Globulin Therpeautic Agent Sales by Type (2021-2032)
  2. 6.1.1 Global Gamma Globulin Therpeautic Agent Sales by Type (2021-2032) & (Kg)
  3. 6.1.2 Global Gamma Globulin Therpeautic Agent Sales Market Share by Type (2021-2032)
  4. 6.2 Global Gamma Globulin Therpeautic Agent Revenue by Type (2021-2032)
  5. 6.2.1 Global Gamma Globulin Therpeautic Agent Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Gamma Globulin Therpeautic Agent Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Gamma Globulin Therpeautic Agent Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Gamma Globulin Therpeautic Agent Sales by Application (2021-2032)
  2. 7.1.1 Global Gamma Globulin Therpeautic Agent Sales by Application (2021-2032) & (Kg)
  3. 7.1.2 Global Gamma Globulin Therpeautic Agent Sales Market Share by Application (2021-2032)
  4. 7.2 Global Gamma Globulin Therpeautic Agent Revenue by Application (2021-2032)
  5. 7.2.1 Global Gamma Globulin Therpeautic Agent Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Gamma Globulin Therpeautic Agent Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Gamma Globulin Therpeautic Agent Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Gamma Globulin Therpeautic Agent Value Chain Analysis
  2. 8.1.1 Gamma Globulin Therpeautic Agent Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Gamma Globulin Therpeautic Agent Production Mode & Process
  5. 8.2 Gamma Globulin Therpeautic Agent Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Gamma Globulin Therpeautic Agent Distributors
  8. 8.2.3 Gamma Globulin Therpeautic Agent Customers
9 Global Gamma Globulin Therpeautic Agent Analyzing Market Dynamics
  1. 9.1 Gamma Globulin Therpeautic Agent Industry Trends
  2. 9.2 Gamma Globulin Therpeautic Agent Industry Drivers
  3. 9.3 Gamma Globulin Therpeautic Agent Industry Opportunities and Challenges
  4. 9.4 Gamma Globulin Therpeautic Agent Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst